Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trialBob W. van Oosten, Chris H. Polman, Mitchell K.P. Lai et al.|Neurology|1997Cited by 268
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advancesJoyce R. Chong, Mitchell K.P. Lai, Nicholas J. Ashton et al.|Journal of Neurology Neurosurgery & Psychiatry|2021Cited by 111
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular diseaseJoyce R. Chong, Christopher Chen, Nicholas J. Ashton et al.|Alzheimer s & Dementia|2021Cited by 99
Longitudinal study of soluble adhesion molecules in multiple sclerosisGavin Giovannoni, E. J. Thompson, Mitchell K.P. Lai et al.|Neurology|1997Cited by 92
F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagyZhidong Zhou, Eng-King Tan, Shin Hui Ng et al.|Human Molecular Genetics|2015Cited by 84